Literature DB >> 8547418

Azole drug resistance as a cause of clinical relapse in AIDS patients with cryptococcal meningitis.

H D Birley1, E M Johnson, P McDonald, C Parry, P B Carey, D W Warnock.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1995        PMID： 8547418     DOI： 10.1177/095646249500600510

Source DB:  PubMed          Journal:  Int J STD AIDS        ISSN： 0956-4624            Impact factor:   1.359


× No keyword cloud information.
  17 in total

Review 1.  Stress, drugs, and evolution: the role of cellular signaling in fungal drug resistance.

Authors:  Leah E Cowen; William J Steinbach
Journal:  Eukaryot Cell       Date:  2008-03-28

Review 2.  Key issues concerning fungistatic versus fungicidal drugs.

Authors:  J R Graybill; D S Burgess; T C Hardin
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1997-01       Impact factor: 3.267

3.  Dynamic and heterogeneous mutations to fluconazole resistance in Cryptococcus neoformans.

Authors:  J Xu; C Onyewu; H J Yoell; R Y Ali; R J Vilgalys; T G Mitchell
Journal:  Antimicrob Agents Chemother       Date:  2001-02       Impact factor: 5.191

4.  Heteroresistance of Cryptococcus gattii to fluconazole.

Authors:  A Varma; K J Kwon-Chung
Journal:  Antimicrob Agents Chemother       Date:  2010-04-12       Impact factor: 5.191

5.  Heteroresistance to fluconazole and voriconazole in Cryptococcus neoformans.

Authors:  P Mondon; R Petter; G Amalfitano; R Luzzati; E Concia; I Polacheck; K J Kwon-Chung
Journal:  Antimicrob Agents Chemother       Date:  1999-08       Impact factor: 5.191

6.  Role of AFR1, an ABC transporter-encoding gene, in the in vivo response to fluconazole and virulence of Cryptococcus neoformans.

Authors:  Maurizio Sanguinetti; Brunella Posteraro; Marilena La Sorda; Riccardo Torelli; Barbara Fiori; Rosaria Santangelo; Giovanni Delogu; Giovanni Fadda
Journal:  Infect Immun       Date:  2006-02       Impact factor: 3.441

7.  Involvement of PDK1, PKC and TOR signalling pathways in basal fluconazole tolerance in Cryptococcus neoformans.

Authors:  Hyeseung Lee; Ami Khanal Lamichhane; H Martin Garraffo; Kyung J Kwon-Chung; Yun C Chang
Journal:  Mol Microbiol       Date:  2012-03-15       Impact factor: 3.501

8.  Correlation of fluconazole MICs with clinical outcome in cryptococcal infection.

Authors:  A I Aller; E Martin-Mazuelos; F Lozano; J Gomez-Mateos; L Steele-Moore; W J Holloway; M J Gutiérrez; F J Recio; A Espinel-Ingroff
Journal:  Antimicrob Agents Chemother       Date:  2000-06       Impact factor: 5.191

9.  Trends in antifungal drug susceptibility of Cryptococcus neoformans isolates in the United States: 1992 to 1994 and 1996 to 1998.

Authors:  M E Brandt; M A Pfaller; R A Hajjeh; R J Hamill; P G Pappas; A L Reingold; D Rimland; D W Warnock
Journal:  Antimicrob Agents Chemother       Date:  2001-11       Impact factor: 5.191

10.  Cryptococcus neoformans overcomes stress of azole drugs by formation of disomy in specific multiple chromosomes.

Authors:  Edward Sionov; Hyeseung Lee; Yun C Chang; Kyung J Kwon-Chung
Journal:  PLoS Pathog       Date:  2010-04-01       Impact factor: 6.823
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.